Definium Therapeutics stock jumps 20% on Phase 3 trial results

This is a summary. Read the complete story at Investing.com below.

Related Stories

stocksabout 2 hours ago

Orbis Medicines partners with Novo Nordisk on $1.4bn drug deal

Investing.com

stocksabout 2 hours ago

GlobalFoundries and Marvell expand chip production deal

Investing.com

stocksabout 2 hours ago

GlobalFoundries, Marvell expand chip capacity deal for AI data center connectivity

Investing.com